753 A phase 1b/2 study of a novel anti-CTLA-4 NEObodyTMADG116 monotherapy and in combination with toripalimab (Tori; Anti-PD-1 Antibody) in patients with advanced/metastatic solid tumors
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.